EFA
RCEL icon

Evernest Financial Advisors’s Avita Medical RCEL Stock Holding History

Evernest Financial Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-50,502
Closed -$411K – 177
2025
Q1 		$411K Buy
+50,502
New +$472K 0.15% 111

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Evernest Financial Advisors's RCEL Position: Q2 2025 in Review

Evernest Financial Advisors sold out of Avita Medical (RCEL) in Q2 2025, closing a stake of 50,502 shares — an estimated $411K sold.

Evernest Financial Advisors first reported a position in RCEL in Q1 2025 and held it in 1 quarter. The position peaked at $411K in Q1 2025. 80 funds tracked by Wall St. Rank hold RCEL as of Q2 2025.

  • Evernest Financial Advisors reported no remaining Avita Medical position as of Q2 2025 after selling out during the quarter.
  • Evernest Financial Advisors sold 50,502 Avita Medical shares in Q2 2025, an estimated $411K.
  • Evernest Financial Advisors first reported a position in Avita Medical in Q1 2025 and held it in 1 quarter.
  • Evernest Financial Advisors's Avita Medical position peaked at $411K in Q1 2025.
  • 80 funds tracked by Wall St. Rank held Avita Medical as of Q2 2025.

Based on Evernest Financial Advisors's 13F filing for Q2 2025, filed 28 Jul 2025.